Compare KOP & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOP | CLPT |
|---|---|---|
| Founded | 1988 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.3M | 494.6M |
| IPO Year | 2006 | N/A |
| Metric | KOP | CLPT |
|---|---|---|
| Price | $28.56 | $12.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $52.50 | $27.67 |
| AVG Volume (30 Days) | 148.8K | ★ 607.8K |
| Earning Date | 11-07-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $1,923,600,000.00 | $34,332,000.00 |
| Revenue This Year | N/A | $18.93 |
| Revenue Next Year | $1.94 | $51.64 |
| P/E Ratio | $37.01 | ★ N/A |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $22.99 | $9.76 |
| 52 Week High | $35.61 | $30.10 |
| Indicator | KOP | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 50.68 | 31.45 |
| Support Level | $27.47 | $13.00 |
| Resistance Level | $29.80 | $13.55 |
| Average True Range (ATR) | 0.90 | 0.71 |
| MACD | -0.02 | 0.14 |
| Stochastic Oscillator | 40.80 | 12.50 |
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.